This Predoctoral Training Program is designed to provide a broad education in the Pharmacological Sciences leading to the Ph.D. degree. The Pharmacological Sciences Training Program (PSTP) is based primarily in the Department of Pharmacology and Chemical Biology at the University Of Pittsburgh School Of Medicine, but includes faculty from three schools within the University and ten departments including Anesthesiology, Chemistry, Immunology, Medicine, Microbiology and Molecular Genetics, Neurobiology, Neurology, Otolaryngology, Pharmaceutical Sciences, and Structural Biology. Graduate students entering this program are typically first recruited into the Interdisciplinary Biomedical Sciences Graduate Program where they join a program that includes core didactic education in biomedical sciences, scientific ethics and statistics and research rotations. Students then transfer into the specialized Ph.D. program of their choice and become candidates for PSTP support in their second year. The training program provides graduate classes in the essential elements of modern pharmacology including neuropharmacology, cancer pharmacology, cardiovascular pharmacology, signal transduction and drug discovery and also the elements or quantitative pharmacokinetics, pharmacodynamics and drug metabolism. Students choose mentors from a well-funded faculty in one of six research areas: Cancer Pharmacology, Cell and Organ System Pharmacology, Drug Discovery, Neuropharmacology. Signal Transduction and Structural Pharmacology. Following completion of the comprehensive exam and a dissertation proposal, students are engaged full time in research in the third and subsequent years of this program. The PSTP also emphasizes training in the responsible conduct of research and provides training in skills (e.g. public presentations) that promote professional development. The PSTP thus provides a contemporary and exciting training opportunity for motivated students within a rich research environment and aims to generate Ph.D. graduates with a broad understanding of the discipline of pharmacology.

Public Health Relevance

Students that participate in this program will receive training in fundamental areas of pharmacology and physiology as well as participate in state of the art research that examines the mechanisms of action of many drugs that are either currently in use or being developed to treat a variety of human diseases. The knowledge gained by these trainees will directly impact human health as they seek to apply this knowledge as either basic researchers, clinicians, educators, business leaders or public policy advocates towards the development of safe and effective drugs.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM008424-19
Application #
8488442
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Okita, Richard T
Project Start
1994-07-01
Project End
2015-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
19
Fiscal Year
2013
Total Cost
$178,618
Indirect Cost
$8,490
Name
University of Pittsburgh
Department
Pharmacology
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Dogan, Snjezana; Hedberg, Matthew L; Ferris, Robert L et al. (2014) Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a low-incidence population. Head Neck 36:511-6
Peffer, Melanie E; Chandran, Uma R; Luthra, Soumya et al. (2014) Caveolin-1 regulates genomic action of the glucocorticoid receptor in neural stem cells. Mol Cell Biol 34:2611-23
Roland, Bartholomew P; Stuchul, Kimberly A; Larsen, Samantha B et al. (2013) Evidence of a triosephosphate isomerase non-catalytic function crucial to behavior and longevity. J Cell Sci 126:3151-8
Song, Gyun Jee; Barrick, Stacey; Leslie, Kristen L et al. (2012) The scaffolding protein EBP50 promotes vascular smooth muscle cell proliferation and neointima formation by regulating Skp2 and p21(cip1). Arterioscler Thromb Vasc Biol 32:33-41
Beckel, Jonathan M; Birder, Lori A (2012) Differential expression and function of nicotinic acetylcholine receptors in the urinary bladder epithelium of the rat. J Physiol 590:1465-80
Quesnelle, Kelly M; Grandis, Jennifer R (2011) Dual kinase inhibition of EGFR and HER2 overcomes resistance to cetuximab in a novel in vivo model of acquired cetuximab resistance. Clin Cancer Res 17:5935-44
Samarasinghe, Ranmal Aloka; Di Maio, Roberto; Volonte, Daniela et al. (2011) Nongenomic glucocorticoid receptor action regulates gap junction intercellular communication and neural progenitor cell proliferation. Proc Natl Acad Sci U S A 108:16657-62
Bartholomew, Janine N; Galbiati, Ferruccio (2010) Mapping of oxidative stress response elements of the caveolin-1 promoter. Methods Mol Biol 594:409-23
Hezel, Michael; de Groat, William C; Galbiati, Ferruccio (2010) Caveolin-3 promotes nicotinic acetylcholine receptor clustering and regulates neuromuscular junction activity. Mol Biol Cell 21:302-10
Choi, Serah; Gamper, Armin M; White, Jason S et al. (2010) Inhibition of ATM kinase activity does not phenocopy ATM protein disruption: implications for the clinical utility of ATM kinase inhibitors. Cell Cycle 9:4052-7

Showing the most recent 10 out of 28 publications